About Us
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries.
Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups and other stakeholders, to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.
To date, MPP has signed agreements with ten patent holders for thirteen HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals and a tuberculosis treatment. MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC).
Featured
MPP in Numbers
patent holders with MPP signed agreements
generic manufacturers and product developers have sublicences from MPP
countries have benefitted from access to MPP-licensed products
ongoing pharmaceutical development projects
Billion dollars saved by the international community, from January 2012 to June 2020
Billion doses of treatment supplied from January 2012 to June 2020
Million patient-years of treatment through MPP’s generic partners, from January 2012 to June 2020
For Everyone Everywhere
Discover where we helped and what we have achieved
Key Publications
Annual Reports
06 October 2020
Twitter Feed

MedicinesPatentPool @MedsPatentPool
“For us it is very important to #LeaveNoOneBehind & irrespective of the level of income, we should make sure #AccessToTreatment is available for all the countries of our region” – @MasoudDara in our latest Partner video 👉 https://t.co/h4S8fJOzR5 #Belarus @WHOEurope @hans_kluge https://t.co/gw9PvT7udv

MedicinesPatentPool @MedsPatentPool
#JustReleased: Straight from @WHO country office in #Belarus, @MasoudDara sheds light on challenges in #TB, need for affordable treatments for #HepC, role of #CivilSociety on the planning table & much more! @WHOEurope ➡️Check out our latest video 🎞️: https://t.co/h4S8fJOzR5 https://t.co/RlC0OhGMP1

MedicinesPatentPool @MedsPatentPool
📢#JustAnnounced: MPP and the Joint Research Centre of the @EU_Commission signed a Memorandum of Understanding to work together in the field of #IntellectualProperty for #COVID19 & beyond ➡️https://t.co/ygvGxYUhZa @CharlieGore @stephen_quest @EUScienceInnov @EU_ScienceHub https://t.co/bHzfbkZt7X

U.S. Pharmacopeia @USPharmacopeia
Join us on 01/28 (9:30 am EDT) for the next #USPCOVIDConnect discussion: Sustaining Access to Quality Medicines Through #PatentPooling. Our guest will be @CharlieGore from @MedsPatentPool. Click here for free registration: https://t.co/v6QyRci1R4 @SireeshaYadlap1 https://t.co/4s6D75KOEt

MedicinesPatentPool @MedsPatentPool
📢Are you a #Community representative or a #CivilSociety expert? MPP is looking for 2 new #Board members to bring your view & voice to our Board. 🗓️Deadline for application: THIS Friday 15 January 2021 Vacancy 1: https://t.co/W3QtWFB15a Vacancy 2: https://t.co/hw9KsL38ym https://t.co/W1o6QWse4P

World Intellectual Property Organization (WIPO) @WIPO
WIPO joins Medicines Patent Pool Governance Board: https://t.co/QdMjgtVZw8 ℹ️ The Medicines Patent Pool is a UN-supported organization working to improve access to medicines for low- and middle-income countries through patent pooling and non-exclusive voluntary licensing. https://t.co/B5Q3GjPluX

MedicinesPatentPool @MedsPatentPool
📢@WIPO joins MPP’s Governance Board, represented by Amy Dietterich, Director of WIPO’s Global Challenges Division. MPP’s ED @CharlieGore: “Bringing the richness of WIPO’s expertise & programs to our Board will complement the diversity of our Board.” ➡️https://t.co/l61hy8rzN3 https://t.co/LVlWKqQ5jh